These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17475749)

  • 1. Oxcarbazepine in youths with autistic disorder and significant disruptive behaviors.
    Kapetanovic S
    Am J Psychiatry; 2007 May; 164(5):832-3. PubMed ID: 17475749
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of oxcarbazepine for treatment-resistant aggression.
    Gaudino MP; Smith MJ; Matthews DT
    Psychiatr Serv; 2003 Aug; 54(8):1166-7. PubMed ID: 12883152
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing disruptive and compulsive behaviors in adult with autistic disorder with gabapentin.
    Guglielmo R; Ioime L; Grandinetti P; Janiri L
    J Clin Psychopharmacol; 2013 Apr; 33(2):273-4. PubMed ID: 23422383
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychopharmacology of autistic disorders].
    Poustka L; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2007 Mar; 35(2):87-94. PubMed ID: 17608278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute oxcarbazepine overdose in an autistic boy.
    Pedrini M; Noguera A; Vinent J; Torra M; Jiménez R
    Br J Clin Pharmacol; 2009 May; 67(5):579-81. PubMed ID: 19552755
    [No Abstract]   [Full Text] [Related]  

  • 6. Topiramate for co-occurring bipolar disorder and disruptive behavior disorders.
    Barzman DH; Delbello MP
    Am J Psychiatry; 2006 Aug; 163(8):1451-2. PubMed ID: 16877668
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of topiramate.
    Kruszewski SP; Klotz SG
    Am J Psychiatry; 2007 Mar; 164(3):526-7; author reply 527-8. PubMed ID: 17329483
    [No Abstract]   [Full Text] [Related]  

  • 8. Memantine for disruptive behavior in autistic disorder.
    Erickson CA; Chambers JE
    J Clin Psychiatry; 2006 Jun; 67(6):1000. PubMed ID: 16848669
    [No Abstract]   [Full Text] [Related]  

  • 9. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT; Goyal P; Grados M; Smith B; Kammann H
    J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment with oxcarbazepine in paroxysmal kinesigenic choreoathetosis.
    Tsao CY
    J Child Neurol; 2004 Apr; 19(4):300-1. PubMed ID: 15163097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for use of mood stabilizers and anticonvulsants in the treatment of nonaffective disorders in children and adolescents.
    Amaladoss A; Roberts N; Amaladoss F
    Clin Neuropharmacol; 2010; 33(6):303-11. PubMed ID: 21079456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of social stories on decreasing disruptive behaviors of children with autism: three case studies.
    Ozdemir S
    J Autism Dev Disord; 2008 Oct; 38(9):1689-96. PubMed ID: 18373187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of obsessive compulsive disorder with oxcarbazepine. A case report.
    McMeekin H
    J S C Med Assoc; 2002 Dec; 98(8):316-20. PubMed ID: 12532658
    [No Abstract]   [Full Text] [Related]  

  • 15. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
    Donovan SJ; Stewart JW; Nunes EV; Quitkin FM; Parides M; Daniel W; Susser E; Klein DF
    Am J Psychiatry; 2000 May; 157(5):818-20. PubMed ID: 10784478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine for mood disorders.
    Nasr S
    Am J Psychiatry; 2002 Oct; 159(10):1793. PubMed ID: 12359694
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Kowatch RA; Emslie GJ; Findling RL; Wilens TE; McCague K; D'Souza J; Wamil A; Lehman RB; Berv D; Linden D
    Am J Psychiatry; 2006 Jul; 163(7):1179-86. PubMed ID: 16816222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine therapy in paroxysmal kinesigenic choreoathetosis.
    Gökçay A; Gökçay F
    Acta Neurol Scand; 2000 May; 101(5):344-5. PubMed ID: 10987326
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder.
    Davids E; Kis B; Specka M; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1033-8. PubMed ID: 16698160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone in young autistic children: replication study and learning measures.
    Kolmen BK; Feldman HM; Handen BL; Janosky JE
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1570-8. PubMed ID: 9394942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.